Search Results - "N. V. Chubar"
-
1
Current Data on the Age-Related Macular Degeneration Pathophysiology: Focus on Growth Factors and Neurotrophins
Published in Advances in gerontology (01-09-2023)“…Age is a main risk factor for age-related macular degeneration (AMD), a complex multifactorial neurodegenerative retinal disease that is becoming the leading…”
Get full text
Journal Article -
2
The role of optical coherence tomography angiography biomarkers in assessing the outcome of long-term anti-VEGF therapy of diabetic macular edema
Published in Rossiĭskiĭ oftalʹmologicheskiĭ zhurnal (03-01-2022)“…The purpose of the study was to assess the changes of biomarkers of diabetic macular edema activity by optical coherence tomography angiography (OCTA) data and…”
Get full text
Journal Article -
3
Clinical efficacy of antiangiogenic therapy for diabetic macular edema in real clinical practice (2-year results)
Published in Rossiĭskiĭ oftalʹmologicheskiĭ zhurnal (20-06-2021)“…Purpose:to evaluate the clinical efficacy of anti-VEGF therapy of patients with diabetic macular edema (DMO) in T & E regimen for 96 weeks. Materials and…”
Get full text
Journal Article -
4
Different types localisation of retinal fluid as prognostic biomarkers in the choice of anti-VEGF therapy for age-related macular degeneration
Published in Vestnik oftal'mologii (2020)“…Age-related macular degeneration is an advanced chronic disease and the main cause of vision loss in geriatric patients. Optical coherence tomography (OCT) is…”
Get more information
Journal Article -
5
Anti-VEGF therapy for age-related macular degeneration
Published in Vestnik oftal'mologii (2018)“…To evaluate the clinical effectiveness of aflibercept in treatment of patients with neovascular age-related macular degeneration (nAMD). The first group…”
Get more information
Journal Article -
6
Clinical associations between photoreceptor status and visual outcomes in diabetic macular edema
Published in Vestnik oftal'mologii (2017)“…to investigate morphological changes and visual acuity response to ranibizumab therapy in patients with different OCT-types of diabetic macular edema (DME) as…”
Get more information
Journal Article -
7
Effectiveness of diffuse diabetic macular edema treatment in relation to structural changes in macular region
Published in Vestnik oftal'mologii (01-07-2016)“…to describe baseline functional and anatomical parameters of the macular region and how they change under ranibizumab therapy depending on the type of diabetic…”
Get more information
Journal Article -
8
Diagnosis and clinical features of non-exudative macular neovascularization
Published in Vestnik oftal'mologii (2023)“…Macular neovascularization (MNV) is the process of new abnormal blood vessels formation in the choroid and/or retina. The widespread adoption of optical…”
Get more information
Journal Article -
9
New findings on pathogenetic mechanisms in the development of age-related macular degeneration
Published in Vestnik oftal'mologii (2022)“…Age-related macular degeneration (AMD) is a complex multifactorial disease that occurs due to disfunction and degeneration of retinal pigment epithelium (RPE)…”
Get more information
Journal Article -
10
AGE- MACULAR DEGENERATION AND GLAUCOMA. EPIDEMIOLOGICAL AND CLINIC-PATHOGENETIC ASPECTS
Published in Sibirskiĭ nauchnyĭ medit︠s︡inskiĭ zhurnal (01-02-2019)“…Nowadays age-related macular degeneration (AMD) and glaucoma are the main causes of the irreversible loss of sight in the developed countries. The analysis of…”
Get full text
Journal Article -
11
GENETIC CRITERIA FOR ANTI-ANGIOGENIC THERAPY FOR TREATMENT OF DIABETIC MACULAR EDEMA
Published in Sibirskiĭ nauchnyĭ medit︠s︡inskiĭ zhurnal (01-02-2019)“…Apart from already established clinical factors, the polymorphic loci of the VEGF gene and its VEGFR2 receptor can have a significant effect on the response to…”
Get full text
Journal Article